[ORGANIZATION]
Sun Pharma
Featured in 7 tracked stories · first seen
Situations
India pharmaceutical regulatory scrutiny
4 clusters · 14 sources · last updated
Latest: India proposes stricter central oversight for antimicrobial drugs
Regulatory authorities in India have intensified oversight of the pharmaceutical sector following reports of widespread quality failures. The Central Drugs Standard Control Organization and state laboratories identified
India economic challenges amid West Asia crisis
128 clusters · 241 sources · last updated
Latest: Indian rupee reaches seven-month peak against US dollar
India’s economic landscape remains defined by foreign exchange volatility and the management of massive capital inflows. Foreign exchange reserves reached a record $740.80 billion for the week ending August 28, driven by
Indian stock market volatility following Muhurat trading
3 clusters · 40 sources · last updated
Latest: Indian stock markets show volatility following Muhurat trading session
The National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) held their annual Muhurat trading session on Sunday, November 8, 2026, to mark the beginning of the Hindu financial year, Samvat 2083. During this spe
Also covered in
-
Bone health research highlights osteoporosis screening and supplement risks
[HEALTH] · 2 sources ·
-
Sun Pharma recalls eye drops in India over contamination
[HEALTH] · 2 sources ·